Report Code: 11669 | Available Format: PDF | Pages: 227
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Test Type
1.3.3 Market Segmentation by Technique
1.3.4 Market Segmentation by Application
1.3.5 Market Segmentation by End User
1.3.6 Market Segmentation by Region
1.3.7 Analysis Period
1.3.8 Market Data Reporting Unit
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Consumables
4.1.1.1.1 Reagents
4.1.1.1.1.1 Fixatives
4.1.1.1.1.2 Stains and dyes
4.1.1.1.1.3 Others
4.1.1.1.2 Antibodies
4.1.1.1.3 Kits
4.1.1.1.4 Probes
4.1.1.1.5 Others
4.1.1.2 Instruments
4.1.1.2.1 Tissue processors
4.1.1.2.2 Slide stainers
4.1.1.2.3 Microtomes
4.1.1.2.4 Centrifuges
4.1.1.2.5 Cryostats
4.1.1.2.6 Others
4.1.2 By Test Type
4.1.2.1 Histopathology
4.1.2.2 Cytopathology
4.1.2.3 Surgical pathology
4.1.3 By Technique
4.1.3.1 Special staining
4.1.3.2 Immunohistochemistry
4.1.3.3 Electron microscopy
4.1.3.4 Genetic testing
4.1.3.5 Others
4.1.4 By Application
4.1.4.1 Disease diagnosis
4.1.4.1.1 Cardiology
4.1.4.1.2 Oncology
4.1.4.1.3 Hepatology
4.1.4.1.4 Nephrology
4.1.4.1.5 Others
4.1.4.2 Drug discovery
4.1.4.3 Others
4.1.5 By End User
4.1.5.1 Diagnostic laboratories
4.1.5.2 Hospitals and clinics
4.1.5.3 Ambulatory surgical centers
4.1.5.4 Academic and research organizations
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Adoption of new technologies
4.2.1.2 Increasing number of collaborations and acquisitions
4.2.2 Drivers
4.2.2.1 Increasing incidence of chronic diseases
4.2.2.2 Rising geriatric population
4.2.2.3 Advancements in technologies
4.2.3 Restraints
4.2.3.1 Increasing market consolidation
4.2.3.2 Lack of monetary support from healthcare insurance providers
4.2.3.3 Inability of underdeveloped countries to adopt digital anatomic pathology
4.2.4 Opportunity
4.2.4.1 Increasing medical tourism in APAC
4.2.4.2 Emerging economies across the world
4.3 Porter’s Five Forces Analysis
4.4 Technological Advancements
4.4.1 WSI
4.4.2 LOC
4.5 Regulatory Framework
4.5.1 North America
4.5.2 Europe
4.5.3 APAC
4.5.4 LATAM
4.5.5 MEA
4.6 Pricing Analysis
Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Consumables Market by Type
5.1.1.1 Reagents market by type
5.1.2 Instruments Market by Type
5.2 By Test Type
5.3 By Technique
5.4 By Application
5.4.1 Disease Diagnosis Market by Type
5.5 By End User
5.6 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 Consumables Market by Type
6.1.1.1 Reagents market by type
6.1.2 Instruments Market by Type
6.2 By Test Type
6.3 By Technique
6.4 By Application
6.4.1 Disease Diagnosis Market by Type
6.5 By End User
6.6 By Country
Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 Consumables Market by Type
7.1.1.1 Reagents market by type
7.1.2 Instruments Market by Type
7.2 By Test Type
7.3 By Technique
7.4 By Application
7.4.1 Disease Diagnosis Market by Type
7.5 By End User
7.6 By Country
Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 Consumables Market by Type
8.1.1.1 Reagents market by type
8.1.2 Instruments Market by Type
8.2 By Test Type
8.3 By Technique
8.4 By Application
8.4.1 Disease Diagnosis Market by Type
8.5 By End User
8.6 By Country
Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 Consumables Market by Type
9.1.1.1 Reagents market by type
9.1.2 Instruments Market by Type
9.2 By Test Type
9.3 By Technique
9.4 By Application
9.4.1 Disease Diagnosis by Type
9.5 By End User
9.6 By Country
Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 Consumables by Type
10.1.1.1 Reagents market by type
10.1.2 Instruments Market by Type
10.2 By Test Type
10.3 By Technique
10.4 By Application
10.4.1 Disease Diagnosis Market by Type
10.5 By End User
10.6 By Country
Chapter 11. Competitive Landscape
11.1 Company Benchmarking Based on Offerings
11.2 Technique Benchmarking of Key Players
11.3 Global Strategic Developments of Key Players
11.3.1 Acquisitions and Collaborations
11.3.2 New Product Launches and Patent Approvals
Chapter 12. Company Profiles
12.1 Key Players
12.1.1 Thermo Fisher Scientific Inc.
12.1.1.1 Business overview
12.1.1.2 Product and service offerings
12.1.1.3 Key financial summary
12.1.2 Danaher Corporation
12.1.2.1 Business overview
12.1.2.2 Product and service offerings
12.1.2.3 Key financial summary
12.1.3 F. Hoffmann-La Roche Ltd.
12.1.3.1 Business overview
12.1.3.2 Product and service offerings
12.1.3.3 Key financial summary
12.1.4 Quest Diagnostics Incorporated
12.1.4.1 Business overview
12.1.4.2 Product and service offerings
12.1.4.3 Key financial summary
12.1.5 Bio-Rad Laboratories Inc.
12.1.5.1 Business overview
12.1.5.2 Product and service offerings
12.1.5.3 Key financial summary
12.1.6 Agilent Technologies Inc.
12.1.6.1 Business overview
12.1.6.2 Product and service offerings
12.1.6.3 Key financial summary
12.1.7 Neogenomics Laboratories Inc.
12.1.7.1 Business overview
12.1.7.2 Product and service offerings
12.1.7.3 Key Financial Summary
12.1.8 Abbott Laboratories
12.1.8.1 Business overview
12.1.8.2 Product and service offerings
12.1.8.3 Key financial summary
12.1.9 Sakura Finetek USA Inc.
12.1.9.1 Business overview
12.1.9.2 Product and service offerings
12.1.10 OriGene Technologies Inc.
12.1.10.1 Business overview
12.1.10.2 Product and service offerings
12.1.11 Biocare Medical LLC
12.1.11.1 Business overview
12.1.11.2 Product and service offerings
12.1.12 Sonic Healthcare Limited
12.1.12.1 Business overview
12.1.12.2 Product and service offerings
12.1.12.3 Key financial summary
12.1.13 DTM Print GmBH
12.1.13.1 Business overview
12.1.13.2 Product and service offerings
12.2 Other Players
12.2.1 Caris Life Sciences Inc.
12.2.2 Sunquest Information Systems Inc.
12.2.3 Inform Diagnostics Inc.
12.2.4 Interpath Laboratory Inc.
Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports
List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2024)
TABLE 5 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2025–2030)
TABLE 6 GLOBAL ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2024)
TABLE 7 GLOBAL ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2025–2030)
TABLE 8 GLOBAL ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 9 GLOBAL ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 10 GLOBAL ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 11 GLOBAL ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 12 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2024)
TABLE 13 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2025–2030)
TABLE 14 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2024)
TABLE 15 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2025–2030)
TABLE 16 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2024)
TABLE 17 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2025–2030)
TABLE 18 GLOBAL ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2024)
TABLE 19 GLOBAL ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2025–2030)
TABLE 20 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2024)
TABLE 21 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2025–2030)
TABLE 22 GLOBAL ANATOMIC PATHOLOGY MARKET, BY REGION, $M (2019–2024)
TABLE 23 GLOBAL ANATOMIC PATHOLOGY MARKET, BY REGION, $M (2025–2030)
TABLE 24 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2024)
TABLE 25 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2025–2030)
TABLE 26 NORTH AMERICA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2024)
TABLE 27 NORTH AMERICA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2025–2030)
TABLE 28 NORTH AMERICA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 29 NORTH AMERICA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 30 NORTH AMERICA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 31 NORTH AMERICA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 32 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2024)
TABLE 33 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2025–2030)
TABLE 34 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2024)
TABLE 35 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2025–2030)
TABLE 36 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2024)
TABLE 37 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2025–2030)
TABLE 38 NORTH AMERICA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2024)
TABLE 39 NORTH AMERICA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2025–2030)
TABLE 40 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2024)
TABLE 41 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2025–2030)
TABLE 42 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2014–2014)
TABLE 43 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2025–2030)
TABLE 44 EUROPE ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2024)
TABLE 45 EUROPE ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2025–2030)
TABLE 46 EUROPE ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2024)
TABLE 47 EUROPE ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2025–2030)
TABLE 48 EUROPE ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 49 EUROPE ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 50 EUROPE ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 51 EUROPE ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 52 EUROPE ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2024)
TABLE 53 EUROPE ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2025–2030)
TABLE 54 EUROPE ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2024)
TABLE 55 EUROPE ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2025–2030)
TABLE 56 EUROPE ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2024)
TABLE 57 EUROPE ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2025–2030)
TABLE 58 EUROPE ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2024)
TABLE 59 EUROPE ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2025–2030)
TABLE 60 EUROPE ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2024)
TABLE 61 EUROPE ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2025–2030)
TABLE 62 EUROPE ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2024)
TABLE 63 EUROPE ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2025–2030)
TABLE 64 APAC ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2024)
TABLE 65 APAC ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2025–2030)
TABLE 66 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 67 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 68 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 69 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 70 APAC ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 71 APAC ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 72 APAC ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2024)
TABLE 73 APAC ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2025–2030)
TABLE 74 APAC ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2024)
TABLE 75 APAC ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2025–2030)
TABLE 76 APAC ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2024)
TABLE 77 APAC ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2025–2030)
TABLE 78 APAC ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2024)
TABLE 79 APAC ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2025–2030)
TABLE 80 APAC ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2024)
TABLE 81 APAC ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2025–2030)
TABLE 82 APAC ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2024)
TABLE 83 APAC ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2025–2030)
TABLE 84 LATAM ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2024)
TABLE 85 LATAM ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2025–2030)
TABLE 86 LATAM ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2024)
TABLE 87 LATAM ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2025–2030)
TABLE 88 LATAM ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 89 LATAM ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 90 LATAM ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 91 LATAM ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 92 LATAM ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2024)
TABLE 93 LATAM ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2025–2030)
TABLE 94 LATAM ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2024)
TABLE 95 LATAM ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2025–2030)
TABLE 96 LATAM ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2024)
TABLE 97 LATAM ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2025–2030)
TABLE 98 LATAM ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2024)
TABLE 99 LATAM ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2025–2030)
TABLE 100 LATAM ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2024)
TABLE 101 LATAM ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2025–2030)
TABLE 102 LATAM ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2024)
TABLE 103 LATAM ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2025–2030)
TABLE 104 MEA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2024)
TABLE 105 MEA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2025–2030)
TABLE 106 MEA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2024)
TABLE 107 MEA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2025–2030)
TABLE 108 MEA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 109 MEA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 110 MEA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2024)
TABLE 111 MEA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2025–2030)
TABLE 112 MEA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2024)
TABLE 113 MEA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2025–2030)
TABLE 114 MEA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2024)
TABLE 115 MEA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2025–2030)
TABLE 116 MEA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2024)
TABLE 117 MEA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2025–2030)
TABLE 118 MEA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2024)
TABLE 119 MEA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2025–2030)
TABLE 120 MEA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2024)
TABLE 121 MEA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2025–2030)
TABLE 122 MEA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2024)
TABLE 123 MEA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2025–2030)
TABLE 124 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE
TABLE 125 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY
TABLE 126 DANAHER CORPORATION – AT A GLANCE
TABLE 127 DANAHER CORPORATION – KEY FINANCIAL SUMMARY
TABLE 128 F. HOFFMANN-LA ROCHE LTD. – AT A GLANCE
TABLE 129 F. HOFFMANN-LA ROCHE LTD. – KEY FINANCIAL SUMMARY
TABLE 130 QUEST DIAGNOSTICS INCORPORATED – AT A GLANCE
TABLE 131 QUEST DIAGNOSTICS INCORPORATED – KEY FINANCIAL SUMMARY
TABLE 132 BIO-RAD LABORATORIES INC. – AT A GLANCE
TABLE 133 BIO-RAD LABORATORIES INC. – KEY FINANCIAL SUMMARY
TABLE 134 AGILENT TECHNOLOGIES INC. – AT A GLANCE
TABLE 135 AGILENT TECHNOLOGIES INC. – KEY FINANCIAL SUMMARY
TABLE 136 NEOGENOMICS LABORATORIES INC. – AT A GLANCE
TABLE 137 NEOGENOMICS LABORATORIES INC. – KEY FINANCIAL SUMMARY
TABLE 138 ABBOTT LABORATORIES – AT A GLANCE
TABLE 139 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY
TABLE 140 SAKURA FINETEK USA INC. – AT A GLANCE
TABLE 141 ORIGENE TECHNOLOGIES INC. – AT A GLANCE
TABLE 142 BIOCARE MEDICAL LLC – AT A GLANCE
TABLE 143 SONIC HEALTHCARE LIMITED – AT A GLANCE
TABLE 144 SONIC HEALTHCARE LIMITED – KEY FINANCIAL SUMMARY
TABLE 145 DTM PRINT GMBH – AT A GLANCE
TABLE 146 CARIS LIFE SCIENES INC. – AT A GLANCE
TABLE 147 SUNQUEST INFORMATION SYSTEMS INC. – AT A GLANCE
TABLE 148 INFORM DIAGNOSTICS INC. – AT A GLANCE
TABLE 149 INTERPATH LABORATORY INC. – AT A GLANCE
List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL ANATOMIC PATHOLOGY MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIG 15 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2030)
FIG 16 GLOBAL ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2030)
FIG 17 GLOBAL ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 18 GLOBAL ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2030)
FIG 19 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2030)
FIG 20 GLOBAL ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2030)
FIG 21 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2030)
FIG 22 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2030)
FIG 23 WORLDWIDE MAJOR MARKETS FOR ANATOMIC PATHOLOGY
FIG 24 NORTH AMERICA ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIG 25 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2030)
FIG 26 NORTH AMERICA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2030)
FIG 27 NORTH AMERICA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 28 NORTH AMERICA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2030)
FIG 29 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2030)
FIG 30 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2030)
FIG 31 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2030)
FIG 32 NORTH AMERICA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2030)
FIG 33 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2030)
FIG 34 NORTH AMERICA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2030)
FIG 35 EUROPE ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIG 36 EUROPE ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2030)
FIG 37 EUROPE ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2030)
FIG 38 EUROPE ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 39 EUROPE ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2030)
FIG 40 EUROPE ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2030)
FIG 41 EUROPE ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2030)
FIG 42 EUROPE ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2030)
FIG 43 EUROPE ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2030)
FIG 44 EUROPE ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2030)
FIG 45 EUROPE ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2030)
FIG 46 APAC ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIG 47 APAC ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2030)
FIG 48 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 49 APAC ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 50 APAC ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2030)
FIG 51 APAC ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2030)
FIG 52 APAC ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2030)
FIG 53 APAC ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2030)
FIG 54 APAC ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2030)
FIG 55 APAC ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2030)
FIG 56 APAC ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2030)
FIG 57 LATAM ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIG 58 LATAM ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2030)
FIG 59 LATAM ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2030)
FIG 60 LATAM ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 61 LATAM ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2030)
FIG 62 LATAM ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2030)
FIG 63 LATAM ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2030)
FIG 64 LATAM ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2030)
FIG 65 LATAM ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2030)
FIG 66 LATAM ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2030)
FIG 67 LATAM ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2030)
FIG 68 MEA ANATOMIC PATHOLOGY MARKET SNAPSHOT
FIG 69 MEA ANATOMIC PATHOLOGY MARKET, BY PRODUCT, $M (2019–2030)
FIG 70 MEA ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, $M (2019–2030)
FIG 71 MEA ANATOMIC PATHOLOGY REAGENTS MARKET, BY TYPE, $M (2019–2030)
FIG 72 MEA ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, $M (2019–2030)
FIG 73 MEA ANATOMIC PATHOLOGY MARKET, BY TEST TYPE, $M (2019–2030)
FIG 74 MEA ANATOMIC PATHOLOGY MARKET, BY TECHNIQUE, $M (2019–2030)
FIG 75 MEA ANATOMIC PATHOLOGY MARKET, BY APPLICATION, $M (2019–2030)
FIG 76 MEA ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY TYPE, $M (2019–2030)
FIG 77 MEA ANATOMIC PATHOLOGY MARKET, BY END USER, $M (2019–2030)
FIG 78 MEA ANATOMIC PATHOLOGY MARKET, BY COUNTRY, $M (2019–2030)
FIG 79 PRODUCT BENCHMARKING OF KEY PLAYERS
FIG 80 TECHNIQUE BENCHMARKING OF KEY PLAYERS
FIG 81 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 82 DANAHER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 83 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2023)
FIG 84 QUEST DIAGNOSTICS INCORPORATED – REVENUE SPLIT BY SEGMENT (2023)
FIG 85 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 86 AGILENT TECHNOLOGIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 87 NEOGENOMICS LABORATORIES INC. – REVENUE SPLIT BY SEGMENT (2023)
FIG 88 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 89 SONIC HEALTHCARE LIMITED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws